Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “TAM”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00201851
What this trial is testing

Adjuvant Oophorectomy and Tamoxifen in Premenopausal Women With Hormone Receptor-Positive Breast Cancer

Who this might be right for
Breast Cancer
International Breast Cancer Research Foundation 740
Testing effectiveness (Phase 2)Active Not RecruitingNCT02311933
What this trial is testing

Tamoxifen Citrate or Z-Endoxifen Hydrochloride in Treating Patients With Locally Advanced or Metastatic, Estrogen Receptor-Positive, HER2-Negative Breast Cancer

Who this might be right for
Recurrent Breast CarcinomaStage III Breast Cancer AJCC v7Stage IIIA Breast Cancer AJCC v7+3 more
National Cancer Institute (NCI) 81
Not applicableLooking for participantsNCT06715046
What this trial is testing

Cell Free DNA Profiling As a Tool to Monitor Clinically-Relevant Events in Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
GVHD - Graft-Versus-Host DiseaseInfections After HSCTTransplant Associated Microangiopathy TAM+2 more
University of Turin, Italy 30
Not applicableNot Yet RecruitingNCT06154590
What this trial is testing

Anastrozole Adjuvant Trial - Study of Anastrozole Compared to NOLVADEX (Tamoxifen Citrate) for Adjuvant Treatment of Early Breast Cancer Clinical Studies), Adjunct Cytotoxic Chemotherapy and Malignant Joint Tumor

Who this might be right for
Metastatic Breast CancerTumorMuscle Neoplasms+1 more
DR. DIANE CHISESI NFS. MD. PHD. 100
Large-scale testing (Phase 3)Study completedNCT00601900
What this trial is testing

Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage IIIB or Stage IV Breast Cancer

Who this might be right for
Invasive Breast CarcinomaRecurrent Breast CarcinomaStage III Breast Cancer AJCC v6+1 more
National Cancer Institute (NCI) 394
Early research (Phase 1)Study completedNCT01231919
What this trial is testing

MK2206 in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Leukemia

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAcute Leukemias of Ambiguous LineageAcute Myeloid Leukemia/Transient Myeloproliferative Disorder+48 more
National Cancer Institute (NCI) 45
Not applicableUnknownNCT02355600
What this trial is testing

Oocyte Recovery During Tamoxifen Adjuvant Therapy

Who this might be right for
Breast Cancer
Instituto de Investigacion Sanitaria La Fe 20
Not applicableStudy completedNCT01157026
What this trial is testing

A Pilot Clinical Trial With Tocotrienol on Breast Cancer

Who this might be right for
Breast Cancer
Malaysia Palm Oil Board 240
Testing effectiveness (Phase 2)Study completedNCT02404844
What this trial is testing

Trial of BKM120/Tamoxifen-combination in Patients With HR-pos, HER2-neg Breast Cancer

Who this might be right for
Breast Cancer
University Hospital, Essen 48
Large-scale testing (Phase 3)Not Yet RecruitingNCT07803783
What this trial is testing

Compare the Efficacy and Safety of YL201 With Standard Chemotherapy in Patients With Metastatic Pancreatic Cancer After Failure of Gemcitabine-Based Systemic Chemotherapy

Who this might be right for
Metastatic Pancreatic CancerPancreatic Ductal Adenocarcinoma (PDAC)
MediLink Therapeutics (Suzhou) Co., Ltd. 320
Large-scale testing (Phase 3)Looking for participantsNCT07502820
What this trial is testing

The POWER Trial: Personalised Dose Optimisation With Adjuvant Tamoxifen Therapy in Breast cancER

Who this might be right for
Breast CancerAdjuvant Drug Therapy
Karolinska Institutet 1,100
Not applicableUnknownNCT04389424
What this trial is testing

Relationship Between Body Composition, Food Consumption, and Micro and Macronutrients With Gene Expression in Breast Cancer

Who this might be right for
Breast CancerEndocrine TherapyEndocrine Therapy Adverse Reaction+3 more
Instituto Jalisciense de Cancerologia 300
Not applicableUnknownNCT03504631
What this trial is testing

Genotyping and Phenotyping of CYP2D6 Breast Cancer Patients on Tamoxifen

Who this might be right for
Breast Cancer Female
Trisakti University 117
Large-scale testing (Phase 3)Study completedNCT00004205
What this trial is testing

Letrozole or Tamoxifen in Treating Postmenopausal Women With Breast Cancer

Who this might be right for
Breast Cancer
ETOP IBCSG Partners Foundation 8,028
Testing effectiveness (Phase 2)UnknownNCT00006369
What this trial is testing

ERA-923 in Treating Postmenopausal Women With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
H. Lee Moffitt Cancer Center and Research Institute
Not applicableStudy completedNCT00827307
What this trial is testing

Zoladex Plus Tamoxifen in Breast Cancer

Who this might be right for
MammographyEstrogenLipemia+2 more
Zhejiang Cancer Hospital 100
Testing effectiveness (Phase 2)Study completedNCT00080743
What this trial is testing

Gefitinib With or Without Tamoxifen in Treating Patients With Tamoxifen-Resistant Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Dartmouth-Hitchcock Medical Center 2
Testing effectiveness (Phase 2)Active Not RecruitingNCT05607004
What this trial is testing

(Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast Cancer

Who this might be right for
Breast NeoplasmsInvasive Breast CancerEstrogen-receptor-positive Breast Cancer+1 more
Atossa Therapeutics, Inc. 87
Testing effectiveness (Phase 2)Study completedNCT00003099
What this trial is testing

Chemoprevention Therapy Plus Surgery in Treating Women With Breast Cancer

Who this might be right for
Breast Cancer
M.D. Anderson Cancer Center 52
Not applicableEnded earlyNCT01155063
What this trial is testing

Evaluating The Safety Of Exemestane Following 2-3 Years Of Adjuvant Tamoxifen Therapy In Postmenopausal Early Breast Cancer Patients

Who this might be right for
Early Breast Cancer
Pfizer 89
Next Page